169 related articles for article (PubMed ID: 33692461)
1. Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies.
Decker M; Lammens T; Ferster A; Erlacher M; Yoshimi A; Niemeyer CM; Ernst MPT; Raaijmakers MHGP; Duployez N; Flaum A; Steinemann D; Schlegelberger B; Illig T; Ripperger T
Leukemia; 2021 Nov; 35(11):3304-3308. PubMed ID: 33692461
[No Abstract] [Full Text] [Related]
2. A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies.
Kirito K; Sakoe K; Shinoda D; Takiyama Y; Kaushansky K; Komatsu N
Haematologica; 2008 Jan; 93(1):155-6. PubMed ID: 18166807
[TBL] [Abstract][Full Text] [Related]
3. Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML).
Owen C
Leuk Res; 2010 Feb; 34(2):141-2. PubMed ID: 19695705
[No Abstract] [Full Text] [Related]
4. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression.
Bluteau D; Glembotsky AC; Raimbault A; Balayn N; Gilles L; Rameau P; Nurden P; Alessi MC; Debili N; Vainchenker W; Heller PG; Favier R; Raslova H
Blood; 2012 Sep; 120(13):2708-18. PubMed ID: 22898599
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
[TBL] [Abstract][Full Text] [Related]
6. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
Hyde RK; Liu P; Friedman AD
Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
[TBL] [Abstract][Full Text] [Related]
7. Making a meal of multiple mutations in acute myeloid malignancies.
Wertheim G; Bagg A
J Mol Diagn; 2011 Nov; 13(6):605-8. PubMed ID: 21907825
[TBL] [Abstract][Full Text] [Related]
8. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
Iizuka H; Kagoya Y; Kataoka K; Yoshimi A; Miyauchi M; Taoka K; Kumano K; Yamamoto T; Hotta A; Arai S; Kurokawa M
Exp Hematol; 2015 Oct; 43(10):849-57. PubMed ID: 26021490
[TBL] [Abstract][Full Text] [Related]
9. Gene of the issue: RUNX1 mutations and inherited bleeding.
Morgan NV; Daly ME
Platelets; 2017 Mar; 28(2):208-210. PubMed ID: 28277065
[No Abstract] [Full Text] [Related]
10. [Allogeneic hematopoietic stem cell transplantation for Familial platelet disorder with a propensity for acute myeloid malignancies with Runx1 germline mutations: a case report and literature review].
Wang LL; Guan J; Cheng P; Zhang T; Cheng H; Zou L
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):517-520. PubMed ID: 35968597
[No Abstract] [Full Text] [Related]
11. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
Schlegelberger B; Heller PG
Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of RUNX1 downstream pathways and target genes.
Michaud J; Simpson KM; Escher R; Buchet-Poyau K; Beissbarth T; Carmichael C; Ritchie ME; Schütz F; Cannon P; Liu M; Shen X; Ito Y; Raskind WH; Horwitz MS; Osato M; Turner DR; Speed TP; Kavallaris M; Smyth GK; Scott HS
BMC Genomics; 2008 Jul; 9():363. PubMed ID: 18671852
[TBL] [Abstract][Full Text] [Related]
13. Validation and clinical application of transactivation assays for RUNX1 variant classification.
Decker M; Agarwal A; Benneche A; Churpek J; Duployez N; Duvall A; Ernst MPT; Förster A; Høberg-Vetti H; Hofmann I; Nash M; Raaijmakers MHGP; Tvedt THA; Vlachos A; Schlegelberger B; Illig T; Ripperger T
Blood Adv; 2022 Jun; 6(11):3195-3200. PubMed ID: 35026845
[TBL] [Abstract][Full Text] [Related]
14. Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder.
Satpathy AT; Briseño CG; Cai X; Michael DG; Chou C; Hsiung S; Bhattacharya D; Speck NA; Egawa T
Blood; 2014 May; 123(19):2968-77. PubMed ID: 24677539
[TBL] [Abstract][Full Text] [Related]
15. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.
Metzeler KH; Bloomfield CD
Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658
[TBL] [Abstract][Full Text] [Related]
16. Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0.
Manchev VT; Bouzid H; Antony-Debré I; Leite B; Meurice G; Droin N; Prebet T; Costello RT; Vainchenker W; Plo I; Diop M; Macintyre E; Asnafi V; Favier R; Baccini V; Raslova H
J Cell Mol Med; 2017 Jun; 21(6):1237-1242. PubMed ID: 27997762
[TBL] [Abstract][Full Text] [Related]
17. Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome.
Jongmans MC; Kuiper RP; Carmichael CL; Wilkins EJ; Dors N; Carmagnac A; Schouten-van Meeteren AY; Li X; Stankovic M; Kamping E; Bengtsson H; Schoenmakers EF; van Kessel AG; Hoogerbrugge PM; Hahn CN; Brons PP; Scott HS; Hoogerbrugge N
Leukemia; 2010 Jan; 24(1):242-6. PubMed ID: 19946261
[No Abstract] [Full Text] [Related]
18. Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia.
Glembotsky AC; Sliwa D; Bluteau D; Balayn N; Marin Oyarzún CP; Raimbault A; Bordas M; Droin N; Pirozhkova I; Washington V; Goette NP; Marta RF; Favier R; Raslova H; Heller PG
Haematologica; 2019 Jun; 104(6):1244-1255. PubMed ID: 30545930
[TBL] [Abstract][Full Text] [Related]
19. Myeloid neoplasms with germ line RUNX1 mutation.
Hayashi Y; Harada Y; Huang G; Harada H
Int J Hematol; 2017 Aug; 106(2):183-188. PubMed ID: 28534116
[TBL] [Abstract][Full Text] [Related]
20. Bone Marrow Morphology Associated With Germline
Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
